Ligand Pharmaceuticals (NASDAQ: LGND)
$70.37
(-0.9%)
-$0.63
Price as of April 25, 2024, 4:00 p.m. ET
Ligand Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ligand Pharmaceuticals Company Info
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.
News & Analysis
Valuation
Earnings Transcripts
Ligand Pharmaceuticals Incorporated (LGND) Q3 2021 Earnings Call Transcript
LGND earnings call for the period ending September 30, 2021.
Motley Fool Transcribers | Nov 10, 2021
Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript
LGND earnings call for the period ending June 30, 2021.
Motley Fool Transcribers | Jul 30, 2021
Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript
LGND earnings call for the period ending March 31, 2021.
Motley Fool Transcribers | May 4, 2021
Ligand Pharmaceuticals Inc (LGND) Q4 2020 Earnings Call Transcript
LGND earnings call for the period ending December 31, 2020.
Motley Fool Transcribers | Feb 3, 2021
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.